Crispr Therapeutics $CRSP has been on a tear since breaking out of its 2017 consolidation at the end of the year. After jumping from below $20 a share in December to over $60 a share in March, it has been stalling. I think there is indeed going to be some consolidation and even bearish correction. However, I think the overall trend is still bullish, and we can anticipate a retest of $60 on the next bullish wave.CRPS Daily Chart(click to enlarge)Bearish Engulfing Candle:- The daily chart shows us the strength of the rally in the past few months.- However, we can see that there was a bearish engulfing candle during the 3/15 session.- Also note the bearish divergence between price and the RSI (price made higher high, but the RSI made a lower high).- These are signs that the market may be a bit overbought.- However, we should respect the prevailing bullish trend.- Essentially, I think the $43-$45 area will be a critical support. - If price gets to $45 in a week or so, it will be testing a support/resistance pivot.- There is a rising trendline support.- Finally, the 50-day simple moving average (SMA).